Clinical Trial Update: Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating two fixed doses of OPC-34712 as adjunctive therapy for adults with major depressive disorder has completed. Results were posted in 2016…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Mental Disorders
• Mood Disorders

Drugs mentioned

• OPC-34712

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Depressive Disorder, Depression | Phase 3 | Status: COMPLETED | Results posted: 2016-01-01